Th1 AdjuvantN-Acetyl-d-Glucosamine Polymer Up-Regulates Th1 Immunity but Down-Regulates Th2 Immunity against a Mycobacterial Protein (MPB-59) in Interleukin-10-Knockout and Wild-Type Mice
Open Access
- 1 October 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (10) , 6123-6130
- https://doi.org/10.1128/iai.69.10.6123-6130.2001
Abstract
Treatment of mice with heat-killed (HK) Mycobacterium bovis BCG or 1- to 10-μm chitin particles (nonantigenic N-acetyl-d-glucosamine polymers) is known to induce innate immune responses, including gamma interferon (IFN-γ) production, which plays a Th1 adjuvant role. However, HK BCG further induces prostaglandin E2-releasing spleen macrophages (Mφ) (PGE2-Mφ), which potentially inhibit Th1 adjuvant activities. We found that chitin particles did not induce PGE2-Mφ formation. To further assess whether chitin has Th1 adjuvant effects, interleukin-10 (IL-10)-knockout (KO) mice and their wild-type (WT, C57BL/6) controls were immunized with a 30-kDa MPB-59 mycobacterial protein mixed with chitin. Immunization with MPB-59 alone induced Th2 responses, characterized by increases in total serum immunoglobulin E (IgE) and specific serum IgG1 levels and spleen Th2 cells producing IL-4, IL-5, and IL-10. No IFN-γ-producing spleen Th1 cells, specific serum IgG2a, or delayed-type hypersentivity (DTH) footpad reactions were detected. On the other hand, chitin–MPB-59 immunization significantly increased spleen Th1 responses, DTH reaction, and serum IgG2a levels along with decreases of Th2 responses. The magnitude of these Th1 adjuvant effects was greater in IL-10-KO mice than in WT mice. In contrast, immunization with HK BCG–MPB-59 showed little or no Th1 adjuvant effect. These data indicate that chitin has a unique Th1 adjuvant effect on the development of Th1 immunity against a mycobacterial antigen. IL-10 down-regulates the adjuvant effect of chitin.Keywords
This publication has 75 references indexed in Scilit:
- Adjuvant Modulation of T-cell Reactivity to 30-kDa Secretory Protein of Mycobacterium Tuberculosis H37Rv and its Protective Efficacy Against Experimental TuberculosisJournal of Medical Microbiology, 1999
- Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway EosinophiliaThe Journal of Experimental Medicine, 1998
- Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary AspergillosisThe Journal of Experimental Medicine, 1997
- An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.The Journal of Experimental Medicine, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Interleukin-10Annual Review of Immunology, 1993
- Defining Protective Responses to Pathogens: Cytokine Profiles in Leprosy LesionsScience, 1991
- Total and anti-mycobacterial ige levels in serum from patients with tuberculosis and leprosyTubercle, 1989
- In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCGJapanese Journal of Cancer Research, 1988
- BCG-Induced Macrophages as Suppressor CellsCancer Investigation, 1983